This premium is directly tied to its status as a triple agonist. While semaglutide only mimics one hormone and tirzepatide mimics two, retatrutides addition of the glucagon pathway increases energy expenditure in research models, making it a highly valuedand therefore costlyasset
Download MeAgain to gamify protein, fiber, hydration, and exercise tracking, capture your Journey Card milestones, and get nudges that keep side effects like muscle loss, severe constipation, and injection site bruising manageable
GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound continue to grow in popularity among patients in Long Island and throughout New York
Reporting helps the MHRA identify safety signals even for products outside the standard licensing framework
The SURPASS program demonstrated HbA1c reductions of 2.0-2.3% at the 15mg dose, with many participants achieving HbA1c below 5.7% (the threshold for normal blood sugar)
The trial also reported better retention rates, with less discontinuation due to side effects than a placebo for lower doses